Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Three-phase pharmaceutical form with constant and controlled release of amorphous active ingredient for single daily application

Three-phase pharmaceutical form with constant and controlled release of amorphous active ingredient for single daily application

US Patent 6042847 · Granted Mar 28, 2000

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Coated particles and pharmaceutical dosage forms2018
Coated particles and pharmaceutical dosage forms2015
Process for the preparation of a pharmaceutical composition comprising ezetimibe2015
Self-microemulsifying drug delivery systems2013
Modified release pharmaceutical composition2009
Stabilized pharmaceutically effective composition and pharmaceutical formulation2004
Stable pharmaceutical formulation comprising a HMG-CoA reductase inhibitor2004
Pharmaceutical formulation with controlled release of active substances2003
Pharmaceutical suspension formulation comprising amoxycillin clavulanic acid and2003
Inclusion complex of nicardipine or its hydrochloride with beta-cyclodextrin and1992
Dispersible cimetidine tablets1991
Dispersible tablets of dihydroergotoxine methanesulfonate and of acid addition s1991